Delivery Order SPE2DB22D2206-SPE2DB25FJF94
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count units) with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets in quantities of seven tablets, valued at $4,719.34. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive award under the company's existing contract vehicle. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. Prevymis...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for PREVYMIS 480 mg tablets (7-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) valued at $4,719.34 under firm fixed pricing. The award was made on August 13, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a delivery order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at approximately $1 billion through December 2026....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging) with a ceiling value of $4,719.34. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for ultimate completion by August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 MG tablets in a quantity of 7 units, valued at $9,438.70. This is a firm fixed price delivery order issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, and the place of performance...
- The Defense Logistics Agency awarded a $4.72K firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded on August 5, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $8,597.04 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561470788 PREVYMIS 240 MG TABLET 7S. This order is being issued against an existing Prime Vendor contract vehicle to supply the antiviral medication PREVYMIS in tablet form to locations within Conshohocken, Pennsylvania, with performance required between July 10-31, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to...
- The Defense Logistics Agency awarded a $8,574.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 480 mg tablets of Prevymis. The delivery order was issued against an existing prime vendor contract vehicle and calls for Amerisourcebergen to provide seven boxes of the antiviral medication to support Department of Defense programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with work scheduled to be...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PREVYMIS 480 MG TABLET 7S, a specialty pharmaceutical product. The contract has a potential value of $8,855.48 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and provides these pharmaceutical supplies to support military treatment programs and facilities. This delivery order is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJF94Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets on August 5, 2025, with a ceiling value of $9,438.70. This firm fixed price delivery order, which is not set aside for any specific business category, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. PREVYMIS (letermovir) is an antiviral medication primarily used for cytomegalovirus prophylaxis in immunocompromised patients undergoing hematopoietic cell transplantation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a billion-dollar prime vendor agreement valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical supplier for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The competitively awarded contract reflects the contractor's established capability to supply specialized pharmaceutical products and medical supplies to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 8/5/25 |